BioAge Labs Inc. (BIOA) Earnings History
Net Loss4 years of earnings data (2022–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
BioAge Labs Inc. (BIOA) Earnings Overview
As of September 24, 2026, BioAge Labs Inc. (BIOA) reported trailing twelve-month net income of -$94M, reflecting -13.1% year-over-year growth. The company earned $-2.11 per diluted share over the past four quarters, with a net profit margin of -896.1%.
Looking at the long-term picture, BIOA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$40M in fiscal 2022.
BioAge Labs Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KYMR (-$300M net income, -794.4% margin), RVMD (-$1.77B net income), LNTH ($275M net income, 15.2% margin), BIOA has room to improve margins relative to the peer group. Compare BIOA vs KYMR →
BIOA Earnings vs Peers
Earnings metrics vs comparable public companies
BIOA Historical Earnings Data (2022–2025)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$81M | -13.4% | -$93M | $-2.24 | -896.1% | -1031.5% |
| 2024 | -$71M | -11.4% | -$78M | $-1.98 | - | - |
| 2023 | -$64M | -60.8% | -$48M | $-1.87 | - | - |
| 2022 | -$40M | - | -$40M | $-1.16 | - | - |
Download Data
Export BIOA earnings history in CSV or JSON format
Free sign-in required to download data
BIOA Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
4+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BIOA — Frequently Asked Questions
Quick answers to the most common questions about buying BIOA stock.
What is BIOA earnings per share (EPS)?
BIOA trailing twelve-month (TTM) diluted EPS is $-2.11, reflecting -13.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2022 to 2025 is available in the table on this page.
What is BioAge Labs Inc.'s net income?
BioAge Labs Inc. (BIOA) trailing twelve-month net income is $-94M as of 2025. Earnings declined -13.1% year-over-year.
Is BIOA profitable?
BIOA is not currently profitable on a TTM basis, reporting a net loss of $-94M. Net margin is -896.1%. Investors should monitor for a return to profitability.
What is BIOA's earnings growth rate?
BIOA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2022 to 2025.
What are BIOA's profit margins?
BioAge Labs Inc. net profit margin is -896.1%, operating margin is -1031.5%, and gross margin is +100.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -27.1%.
Is BIOA growing earnings?
BIOA earnings are declining — EPS fell -13.1% year-over-year. TTM net income dropped to $-94M. This contrasts with the 5-year CAGR of N/A.
What was BIOA's best earnings year?
BioAge Labs Inc.'s highest annual net income on record is $-40M, achieved in fiscal year 2022. Earnings history on this page spans 2022 to 2025 and includes all annual and quarterly figures.
What were BIOA's earnings last quarter?
BIOA's most recent reported quarter was Q2 2026. Net income was $-26M with diluted EPS of $-0.58. For a full breakdown of all quarters, see the quarterly earnings table on this page.